AMPH – amphastar pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) had its price target lowered by analysts at Piper Sandler from $36.00 to $32.00. They now have a "neutral" rating on the stock.
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks [Yahoo! Finance]
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference [Yahoo! Finance]
Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1% [Yahoo! Finance]
Form 4 Amphastar Pharmaceutical For: Apr 01 Filed by: Petersen Floyd F.
Form PRE 14A Amphastar Pharmaceutical For: Jun 02
Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.
Form 4 Amphastar Pharmaceutical For: Mar 15 Filed by: Zhou Rong
Form 4 Amphastar Pharmaceutical For: Mar 14 Filed by: Luo Mary Z.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.